Imiquimod is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Imiquimod.
| Product ID | 51672-4145_cd5069f0-4bdf-46cf-8278-cc821732f5c8 |
| NDC | 51672-4145 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Imiquimod |
| Generic Name | Imiquimod |
| Dosage Form | Cream |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2011-04-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA200173 |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | IMIQUIMOD |
| Active Ingredient Strength | 50 mg/g |
| Pharm Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-04-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA200173 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-04-15 |
| Marketing Category | ANDA |
| Application Number | ANDA200173 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-04-15 |
| Ingredient | Strength |
|---|---|
| IMIQUIMOD | 50 mg/g |
| SPL SET ID: | 59af8153-4cf8-4f22-9000-f239798d52d1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-3133 | Imiquimod | imiquimod |
| 0168-0432 | imiquimod | imiquimod |
| 45802-368 | Imiquimod | Imiquimod |
| 51672-4145 | Imiquimod | Imiquimod |
| 51672-4174 | Imiquimod | Imiquimod |
| 52549-4145 | Imiquimod | Imiquimod |
| 63629-8818 | Imiquimod | imiquimod |
| 64380-773 | imiquimod | imiquimod |
| 68462-536 | Imiquimod | Imiquimod |
| 68682-272 | Imiquimod | imiquimod |
| 72189-084 | IMIQUIMOD | IMIQUIMOD |
| 99207-260 | Aldara | imiquimod |
| 99207-270 | Zyclara | imiquimod |
| 99207-271 | Zyclara | imiquimod |
| 99207-276 | Zyclara | imiquimod |